• Info
  • Insider Ownership

Insider Trading & Ownership of Robert R. Ruffolo

Location
Madison, NJ
Signature
/s/ Marc Panoff, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Robert R. Ruffolo and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Robert R. Ruffolo has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Aridis Pharmaceuticals, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Robert R. Ruffolo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARDS Aridis Pharmaceuticals, Inc. Director 05 Dec 2022
ELTX Elicio Therapeutics, Inc. Director 19 May 2025
LBRX LB PHARMACEUTICALS INC Director 10 Sep 2025
SGTX Sigilon Therapeutics, Inc. Director 11 Aug 2023

Insider Transactions Reported by Robert R. Ruffolo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored